Dr. Van Hove is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
13123 E 16th Ave
Aurora, CO 80045Phone+1 720-777-1234Fax+1 720-777-7321
Education & Training
- Duke University HospitalResidency, Pediatrics, 1990 - 1994
- Catholic University of LeuvenClass of 1986
Certifications & Licensure
- CO State Medical License 2003 - 2025
- NC State Medical License 1994 - 2025
- American Board of Medical Genetics and Genomics Clinical Biochemical Genetics
- American Board of Medical Genetics and Genomics Clinical Genetics and Genomics
Clinical Trials
- A Phase 1b Study of the Safety of REN001 in Patients With Fatty Acid Oxidation Disorders Start of enrollment: 2019 Apr 04
Publications & Presentations
PubMed
- 1 citationsSuccessful liver transplantation in hyperornithinemia-hyperammonemia-homocitrullinuria syndrome: Case report.Pauline De Bruyne, Patrick Verloo, Johan L.K. Van Hove, Bernard de Hemptinne, Saskia Vande Velde
Pediatric Transplantation. 2021-09-01 - 12 citationsEnantiomer-specific pharmacokinetics of D,L-3-hydroxybutyrate: Implications for the treatment of multiple acyl-CoA dehydrogenase deficiency.Willemijn J. van Rijt, Johan L.K. Van Hove, Frédéric M. Vaz, Rick Havinga, Derk P. Allersma
Journal of Inherited Metabolic Disease. 2021-02-05 - 42 citationsConsensus guidelines for the diagnosis and management of pyridoxine-dependent epilepsy due to α-aminoadipic semialdehyde dehydrogenase deficiencyCurtis R. Coughlin, Laura A. Tseng, Jose E. Abdenur, Catherine Ashmore, François Boemer
Journal of Inherited Metabolic Disease. 2021-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: